TW422697B - Energy-supplementing saccharide source and its uses - Google Patents
Energy-supplementing saccharide source and its uses Download PDFInfo
- Publication number
- TW422697B TW422697B TW083102441A TW83102441A TW422697B TW 422697 B TW422697 B TW 422697B TW 083102441 A TW083102441 A TW 083102441A TW 83102441 A TW83102441 A TW 83102441A TW 422697 B TW422697 B TW 422697B
- Authority
- TW
- Taiwan
- Prior art keywords
- trehalose
- energy
- weight
- sugar
- supplement
- Prior art date
Links
- 150000001720 carbohydrates Chemical class 0.000 title claims abstract description 10
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 122
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 121
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 121
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 36
- 239000008103 glucose Substances 0.000 claims abstract description 36
- 108090000790 Enzymes Proteins 0.000 claims abstract description 25
- 102000004190 Enzymes Human genes 0.000 claims abstract description 25
- 229920002472 Starch Polymers 0.000 claims abstract description 16
- 235000019698 starch Nutrition 0.000 claims abstract description 16
- 239000008107 starch Substances 0.000 claims abstract description 16
- 239000007787 solid Substances 0.000 claims abstract description 9
- 239000000413 hydrolysate Substances 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 5
- 235000013305 food Nutrition 0.000 claims abstract description 4
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 3
- 239000002537 cosmetic Substances 0.000 claims abstract 2
- 235000000346 sugar Nutrition 0.000 claims description 49
- 239000013589 supplement Substances 0.000 claims description 31
- 238000011049 filling Methods 0.000 claims description 23
- 150000008163 sugars Chemical class 0.000 claims description 14
- 238000004440 column chromatography Methods 0.000 claims description 8
- 230000002079 cooperative effect Effects 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 7
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 5
- 241001474374 Blennius Species 0.000 claims description 5
- 238000007911 parenteral administration Methods 0.000 claims description 5
- 239000003729 cation exchange resin Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 230000009471 action Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000002825 nitriles Chemical class 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 54
- 239000004615 ingredient Substances 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 3
- 238000011282 treatment Methods 0.000 abstract description 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 40
- 238000000034 method Methods 0.000 description 31
- 239000000243 solution Substances 0.000 description 30
- 238000002474 experimental method Methods 0.000 description 27
- 239000000843 powder Substances 0.000 description 25
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 22
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 19
- 241000283973 Oryctolagus cuniculus Species 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 239000013078 crystal Substances 0.000 description 12
- 102000004877 Insulin Human genes 0.000 description 11
- 108090001061 Insulin Proteins 0.000 description 11
- 229940125396 insulin Drugs 0.000 description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 9
- 235000020357 syrup Nutrition 0.000 description 9
- 239000006188 syrup Substances 0.000 description 9
- 229930006000 Sucrose Natural products 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 235000015170 shellfish Nutrition 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 4
- 102000013142 Amylases Human genes 0.000 description 4
- 108010065511 Amylases Proteins 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 108010009736 Protein Hydrolysates Proteins 0.000 description 4
- 235000019418 amylase Nutrition 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 150000002016 disaccharides Chemical class 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000013345 egg yolk Nutrition 0.000 description 4
- 210000002969 egg yolk Anatomy 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- -1 sorbitan Sugar alcohol Chemical class 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 239000004097 EU approved flavor enhancer Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000019264 food flavour enhancer Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000832 lactitol Substances 0.000 description 2
- 235000010448 lactitol Nutrition 0.000 description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 2
- 229960003451 lactitol Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229910052704 radon Inorganic materials 0.000 description 2
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002627 tracheal intubation Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102100033770 Alpha-amylase 1C Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 102100027819 Cytosolic beta-glucosidase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 1
- 101000779870 Homo sapiens Alpha-amylase 1B Proteins 0.000 description 1
- 101000779869 Homo sapiens Alpha-amylase 1C Proteins 0.000 description 1
- 101000859692 Homo sapiens Cytosolic beta-glucosidase Proteins 0.000 description 1
- 101000997662 Homo sapiens Lysosomal acid glucosylceramidase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000589187 Rhizobium sp. Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 101150073877 egg-1 gene Proteins 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 239000008371 vanilla flavor Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/10—Chewing gum characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/346—Finished or semi-finished products in the form of powders, paste or liquids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L15/00—Egg products; Preparation or treatment thereof
- A23L15/20—Addition of proteins, e.g. hydrolysates, fats, carbohydrates, natural plant hydrocolloids; Addition of animal or vegetable substances containing proteins, fats, or carbohydrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L15/00—Egg products; Preparation or treatment thereof
- A23L15/30—Addition of substances other than those covered by A23L15/20 – A23L15/25
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L9/00—Puddings; Cream substitutes; Preparation or treatment thereof
- A23L9/10—Puddings; Dry powder puddings
- A23L9/12—Ready-to-eat liquid or semi-liquid desserts, e.g. puddings, not to be mixed with liquids, e.g. water, milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C13—SUGAR INDUSTRY
- C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
- C13K13/00—Sugars not otherwise provided for in this class
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
- A23G2200/06—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing beet sugar or cane sugar if specifically mentioned or containing other carbohydrates, e.g. starches, gums, alcohol sugar, polysaccharides, dextrin or containing high or low amount of carbohydrate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/33—High-energy foods and drinks, sports drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/636—Trehalose
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Animal Husbandry (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
經濟部中央標隼局員工消費合作社印製 422697 at B7五、發明説明(} 發明背景 1 .發明領域 本發明係有關於一種補充能量用之糖類來源以及其用 途,.更特別地,係有關於一種主要由海藻糖(trehalose )組成之補充能量糖類來源,以及一種含該海藻糖作爲有 效成份之補充能量組成物,其中該海藻糖係由一包含令非 還原糖生成酶作用在具還原力之部分澱粉水解物的步驟之 方法而製得。 2 .先前技藝之說明 具有還原力之糖類,如葡荀糖與果糖,長久以來便已 被用作爲補充能量用之糖類來源。但是這些糖類因其還原 力而具有較差的貯存安定性,而且通常會因其他營養素, 如胺基酸與維生素,之存在而變得更不安定。 所以極需建立一種主要由非還原糖,如木糖醇,山梨 糖醇,麥芽糖醇(maltitDl),乳糖醇(lactitol),蔗 糖或海藻糖,所組成之補充能量糖類來瀕。在這些非還原 糖中,單糖之糖醇,如木糖醇與山梨糖醇具有下述缺點: 當以錯誤的劑量與路徑施用至體內時,將引起嚴重的腹瀉 。雙糖之糖醇,如麥芽糖醇與乳糖醇,如日本專利公開第 1 3 ,699/72 與 52 ,50 6/7 2 號所揭示的, 並不易被活體所代謝與利用,且實際上業已被用作爲節食 甜味劑。所以這些雙糖類不適合作爲補充能量之糖類來源 I. 裝 訂 線 (請先W讀背面之注項再填寫本頁) 本紙張尺度適用中國國家標準(CNS)A4規格(210X297公釐>_ 4 - 83.3. 10,000 422697 經濟部中央標準局員工消费合作社印製 A7 B7五、發明説明(2 ) 。蔗糖之缺點爲易被水解成還原性菊萄糖,而果糖在酸性 條件下則具有很差之貯存安定性◊然如日本公開特許公報 2 4 0,7 5 8/8 8所揭示的說明:「海藻糖爲低熱量 的,因爲它幾乎不爲身雔所吸收消化與利用」,以及「海 藻糖幾乎不爲澱粉酶等所水解」,故海藻糖業經被認定成 一種無法於體內作爲能量來源之糖類來源。 發明簡述 至今實極需確立一種補充能量用之糖類來源,其可以 工業規模輕易製得,且幾乎不具還原力,而具有令人滿意 之貯存安定性與廣泛的利用性:以及一種補充能量糖類來 源作爲有效成份之補充能量用之組成物。 本案發明人曾硏究可以工業規模輕易製得之補充能量 糖類來源,更特別地,係積極硏究一種非還原性與安定雙 糖,即海藻糖,以及其相關物質。最後吾人發現海藻糖( Ο—π — D -吡哺萄糖基e-D —吡喃萄糖苷或α 海藻糖)〔其係由日本專利申請案第3 6 2 ,Ί 3 1/ 9 2與2 6 5 ,4 1 6 / 9 3號所揭示之新穎生化技術所 製得,前述二申請案均爲本案發明人所申請〕可於體內輕 易地代謝,而爲活體利用作爲能量來源。吾人亦發現此一 生化技術有利於以工業規模產製海藻糖,該方法包括一令 非還原糖生成酶作用在具還原力之部分澱粉水解物的步驟 (「具還原力之部分澱粉水解物」一詞在下文中稱爲「還 原性部分激粉水解物」)。吾人更發現到由此生化技術製 I I I I I n I ^ n n n n n n 線 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度逍用中國國家梯準(CNS > A4規格(2丨0X297公釐) 83.110,000 經濟部中央樣準局貝工消费合作社印製 :422697 A7 B7_五、發明説明() 〇 得之海藻糖係一完全新穎之補充能量糖類來源,且因其非 還原性,故具廣泛之應用性,進而確立了一種含該海藻糖 作爲有效成份之補充能置用組成物。本發明之補充能量用 組成物可任意地與其他營養素及/或藥物混合使用,並形 成複合營養組成物與醫薬組成物,且因爲其中併入之海藻 糖具有較高貯存安定性且幾乎不具還原力,所以此等組成 物具有較佳轚療功效。 圖式之簡耍說明 圖1顯示人類口服海藻糖或葡萄糖後,時間過程中之 血糖濃度。 圖2顯示人類口服海藻糖或葡萄糖後,時間過程中之 胰島素濃度。 圖3顯示兔子在非經腸快速投與海藻糖或葡萄糖後, 時間過程中之血糖濃度。 圖4顯示兔子在非經腸快速投與海藻糖或葡萄糖後, 時間過程中之胰島素濃度。 圖5顯示兔子在非經腸慢速投與海藻糖或葡萄糖後, 時間過程中之血糖濃度。 圖6顯示兔子在非經腸慢速投與海藻糖或葡荀糖後, 時間過程中之胰島素濃度。 在所有圖中,實線表示海藻糖之動力學,虛線則表示 葡萄糖之動力學。 (請先《讀背面之注意事項再填寫本頁) 本纸張尺度逍用中國國家揉準(CNS ) A4規格(210><297公釐) 83.3.10,000
經濟部中央橾準局貝工消費合作社印製 五、發明説明(4 ) 發明夕詳細說明 本發明係有關於一種補充能量用之糖類來源以及其用 途,更特別地,係有關於一種主要由海藻糖組成之補充能 量糖類來源,以及一種含該海藻糖作爲有效成份之補充能 ‘量組.成物,其中該海藻糖係由一包含令非還原糖生成酶作 用在具還原力之部分澱粉水解物的步驟之方法而製得。 本案之補充能量用糖類來源主要由海藻糖組成,該海 藻糖係由一包含令非還原糖生成酶作用在還原性部分澱粉 水解物的步驟之方法製得,以及本案含該海藻糖作爲有效 成份之補充能量組成物均未曾被報導過。 本發明之補充能量糖類來源包括那些含可能最高濃度 海藻糖者,且通常爲那些呈糖漿與粉末形式者,且其海藻 糖含量爲5 Ow/w%或更高,基於乾固體重(「w/w %」與「基於乾固體重j在本說明書中若無特別說明,分 別縮寫爲「%」與「d. s. b.」),較好爲那些呈糖 漿與晶狀粉末形式者,且其海藻糖含量爲8 0 %或更高, d. s. b.,更佳者是那些呈晶狀粉末與晶體形式者, 且其海藻糖含量爲9 (3%或更高,d. s. b.。 海藻糖之任何製備方法均可用於本發明中,只要該方 法包含有下述步驟:令非還原糖生成酶作用在還原性部分 灘粉水解物,例如日本專利申請案第3 6 2,1 3 1/ 9 2與2 6 5,4 1 6/9 3號所揭示的製備方法,在該 方法中係令非還原糖形成酶作用在葡萄糖聚合度爲了或更 高之還原性部分澱粉水解物上以製得海藻糖。前述方法便 本紙張尺度逋用中國國家揉準(CNS)A4说格(210X297公釐) 了 _ 83.3.10,000 -- (請先閲讀背面之注$項再填寫本頁) *言 422697 經濟部中央揉準局負工消费合作社印製 A7 B7五、發明説明(5 ) 可適合且便利地用於本發明中,因其達成海藻糖之工業規 模產製。 上述製法所得糖類溶液通常含有約2 0 - 8 0 %海藻 糖,d. s . b.,同時並含有還原糖類,如葡荀糖,麥 芽糖與麥芽三糖等。 以慣用方式將此糖類溶液製成糖漿製品,即以凝膠過 濾與離心移除溶液中的雜質,連續以活性碳脫色純化所得 溶液,以Η -型與0H —型離子交換樹脂脫鹽,濃縮所得 經純化溶液。此糖漿製品可乾燥成粉末產物。若需要,最 高可能純度之海藻糖製品可藉由兩種純化或多種純化混合 應用而輕易製得,例如,管柱色層分析,如離子交換管柱 層析,以及使用活性碳或矽膠之管柱層析:使用如醇類或 丙酮等有機溶劑之分離法:使用具適當分離性之膜來分離 :以及其他用鹸處理或酵母醱酵來分解或移除殘留還原糖 類之方法。 更特別地,於本案中離子交換管柱層析可適宜地用於 最高可能純度海藻糖之工業規模製備,例如,海藻糖溶液 原料中之海藻糖含量可藉下法輕易地提高:如日本公開特 許公報第23,799/83與72,598/83號所 揭示,以强酸性陽離子交換樹脂之管柱層析法將溶液中之 雜質移除。管柱層析時,可用固定牀,移動牀與僞移動法 (pseudoraoving-methods ) 0 在本發明中,只要是含有海藻糖作爲有效成份且可補 充活體能量用補充能置組成物均可使用,其中該海藻糖係 (請先W讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家揉準(CNS } A4规格(2丨0><297公釐) 83.3.10,000 422697 A7 B7 經濟部中央揉準局貝工消费合作社印製 五、發明説明(6 ) 由一包括以非還原糖生成酶作用在還原性部分澱粉水解物 步驟之方法製得。通常爲了達成較佳效果,併入組成物中 之海藻糖數量爲10%以上,較好20%以上,d. S. b . 0 .本案補充能量組成物包括那些僅含海藻糖者,或是還 混有一種或多種可食物質與可投與活體之其他物質,例如 ,藥物,如蛋白質,胺基酸,脂質,不爲海藻糖之糖類, 維生素,礦物質,防腐劑,酵素,激素與胞激肽。若需要 ,亦可併入一種或多種其他適宜物質,如增味劑,色素, 增香劑,安定劑,塡料與賦形劑。如此所得組成物可形成 適當形式。 本案組成物可以口服或非經腸地投與至活體,而於體 內有效地被代謝與利用作爲補充能量物質,且不會產生毒 性與副作用。 本案補充能量之糖類來源的劑量可適當地選擇在如下 範圍內:海藻糖之量爲約1至1 0 0 Og/天/成人,較 好爲約5至500g/天/成人,d. s. b.。 本案補充能量用之糖類來源以及含彼之組成物可被投 給人類,家畜,如牛與馬,以及寵物,如狗與貓,等等。 下述實驗詳述本發明內容: 實驗1 裝 訂 線 (請先閲讀背面之注意事項再填寫本頁) 海藻糖之製備
本紙張尺度適用中國國家搮準(CNS)A4規格( 210X297公釐)83.3. !〇,〇〇〇 --公告各-87 M _ 非還原糖生成豳作用之製備 1-------------------------- (請先閲讀背面之注意事項再填寫本頁) 根據日本專利申請案第362 ,131/92號揭示的方法,將 培養起始物(seed culture) ,Rhizobium sp . M-ll( FERM BP-4130),置於一由 2.0w/v^^芽糖,0.5w/v% 戊糖 ,O.lw/v%酵母萃取物,O.lw/v%磷酸氫二納,0.1界/4磷 酸二氫鉀及水組成之營養培養基(PH7. 0 )中,通氣攪動 及2 7°C下*培養36小時。培養完成後,將所得培養物 以S F膜過濾而移除細胞,得到約1 8升的濾液,再將之 以U F膜過濾濃縮得到約1升溶液,其活性爲17. 7單位/ 毫升非還原糖生成酶。 音驗1 一 2 含水晶狀海蕩糖之製備 經濟部中央橾準局員工消費合作社印袈 將 40 重量份「PINE-DEX # 4 j ( Matsutan i Chemical Ind. , Co., Ltd. , Kyoto, Japan 販售之還原性部分澱粉水解物)加熱溶於6 0重量份水中 ,並將所成溶液加熱至45°C,調整至pH6. 5,相對 於每克還原性部分澱粉水解物,混入1單位之非還原糖生 成酶(以實驗1-1的方法製得),培養96小時後將所 成混合物於1 0 0°C加熱1 0分鐘使殘留的酶失去活性》 令如此所得溶液稀釋至約20%,d. s. b.之濃度, 以相對於每克還原性部分澱粉水解物•混入1 0單位之「 G L U C 0 Ζ Υ Μ E」(N a g a s e B i 〇 c h e m i c a I s,L t d.,K y 〇 t 〇, Japan,販售之葡萄澱粉酶試樣),培養4 0小時,再將 所成混合物加熱使殘留的酶失去活性。所得溶液藉慣用方 本紙乐尺度適用中國固家標準(CNS) A4規格(2丨0X297公釐) -10 - 經濟部中央標準局員工消費合作社印装 422697 at ___B7___ 五、發明説明(8 ) 式以活性碳脫色,以離子交換樹脂脫鹽,澳縮成約6 0 % 之溶液,其含約29. 5%海藻糖,d. s. b.。將此 濃縮後之溶液送入裝塡有「CG 60〇〇,Na型」( J a p a n 0 r g a n l C 〇 ^ L t d .,T 〇 k y 〇 , J a p a η 販售之强酸性 陽離子交換樹脂)之備有套管的不銹鋼管柱,於6 〇°C及 SV (空間速率)爲0 . 4情況下進行分離,接著回收海 藻糖高含量之部分,其含約90%海藻糖,d. s. b. 。此部分被濃縮成約75%溶液,d. s. b.,再移至 結晶器中,與約2 %含水晶狀海藻糖(作爲晶種)混合, 加熱至5 0°C,輕微搅拌下慢慢冷卻至2 5°C,以籃式離 心機分離。藉著噴灑少量水而清洗所得晶體,得到純度爲 99%以上,d. s. b.,之高純度含水晶狀海藻糖。 窗驗1 — 3 晶狀海藩糖粉末之製備 根據實驗1 一 2方法製得結晶度約爲4 5%之白糖, 令之從乾燥塔頂端上之噴嘴以1 5 0 k g/cm2的壓力 噴灑出。在此噴灑步驟中,令內裝物受來自乾燥塔上部之 8 5 °C熱空氣吹拂,並將所得晶狀粉末收集在乾燥塔底層 (basement)之金屬網输送器,並一面以從該金屬網輪 送器下送出之4 5 °C熱空氣吹拂之,一面回收之,最後慢 慢地送出乾燥塔。將所得晶狀粉末注入老化塔(ageing t 〇 w e r ),以熱空氣吹拂完成結晶並乾燥而老化1 0小時 ,接著回收所成晶狀海藻糖粉末。 本紙张又度適用中固圏家揉準(CNS 規# ( 210X297公瘦)_ η, . 83. 3.10,000 ----------^------ΐτ------^ (請先Μ讀背面之注意事項再填寫本頁) 經濟部中央標準局男工消費合作社印製 4226 9 7 377五、發明説明(9 ) 實驗1 — 4 無7k晶狀海蓬糠粉末之製備 將實驗1 - 2之方法製得之海藻糖漿配成約6 0%溶 液,.然後根據實驗1 一 2的方法以强酸性陽離子交換樹脂 令之進行管柱層析,得到含約95%海藻糖,d. s. b .,之高海藻糖含量部分。根據日本專利申請案第 2 6 5,4 1 6/9 3號之方法,將此部分置於容器中, 眞空中煮沸成含水量約4. 0%的糖漿,然後移至結晶器 中,混入1 %無水晶狀海藻糖(基於糖漿乾固體重)作爲 晶種,接著於9 5 eC,授拌中令海藻糖結晶5分鐘。將所 得移至鋁製容器中以1 0 0 °C老化6小時,形成團塊,利 用切割器(cutter)將之粉碎,並以流體牀乾燥器乾燥得 出無水晶狀海藻糖粉末,含水量爲約0. 3%。 窗驗2 體外消化試驗 使用實驗1 — 2方法製得之高純度含水晶狀海藻糖的 溶液進行體外消化試驗,此試驗係根據K. Okada等人, JOURNAL OF JAPANESE SOCIETY OF NUTRITION AND FOOD SCIENCE, Vol.43, No.1, pp.23 - 29 ( 1 99 0 )所述方法進行 。海藻糖的可消化性係以分解率(% )評估之,分解率由 下式算出: ----------^------ir------0 (請先閲讀背面之注意ί項再填寫本頁) 本紙張尺度適用中國國家揉準(CNS ) Α4規格(210X297公釐) 83. 3.10,000 12
42269T A 7 B7 五、發明説明(1()) 還原糖 分解率(% ) = -X 1 0 0 全部的糖 .結果示於表1。 表1 酶 分解率(% 唾液澱粉酶 0 . 0 胃酸 0 . 0 胰澱粉酶 0 . 0 得自老鼠小腸黏膜之酶 1 . 3 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印裝 如表1結果所示,海藻糖幾乎不爲得自老鼠小腸黏膜 之酶所水解。以此得自老鼠之酶,同上述方法般測試雙糖 之可消化性。 結果示於表2。 本紙張尺度適用肀國國家標率(CNS ) A4規格(210X297公釐) 83.3.10,000 -13 - 4226^ A7 B7 五、發明説明(u) 表2 雙煻 分解率(%) 麥芽.糖 8 0.1 蔴糖 2 5.1 異麥芽糖 13.2 乳糖 9.7 纖維二糖 1 . 2 海藻糖 1 · 3 (請先閲讀背面之注^項再填寫本頁) 經濟部中央揉準局貝工消费合作社印裝 如表2結果所示,海藻糖被得自老鼠之酶水解的程度 遠較麥芽糖爲低。 音驗3 經由口服之體內利用試賒 根據 H. Atsuji 等人,Journal of Clinical Nutrition, Vol. 41, No.2, pp.200-208 (1972),所述 方法,將3 0 g實驗1 _ 2製得之含水晶狀海藻糖溶於水 中製成2 0 w/v %海藻糖水溶液,將預定量之該溶液口 服施與6位男性志願者(2 6 — 3 1歲)。在預定時間間 隔,對志願者取血,測量每個血液試樣之血糖濃度,即葡 萄糖濃度(mg/d$),與胰島素濃度 本紙張又度逋用中國國家標準(CNS)A4洗格( 210X297公釐)-14 - 83.3.10,〇〇〇 經濟部中央標隼局貝工消费合作社印製 422697 A7 B7五、發明説明(12) 。對照組則以葡荀糖進行試驗。上述二濃度之結果爲6位 志願者之平均値。圖1與圖2各別顯示時間過程中之血糖 濃度與胰島素濃度。在圖中,實線與虛線各代表海藻糖與 葡萄糖之結果。 .由圖1與圖2結果得知,雖然投與海藻糖之兔子顯示 之動力情形似乎較投與葡萄糖者有一時間上的延遲,然投 與海藻糖者顯示與投與葡萄糖者類似的動力情形,亦即, 海藻糖在投與約3 0 — 4 5分鐘後產生血糖濃度與胰島素 濃度之最大値。不同於實驗2體外消化試驗的結果,本實 驗結果透露出海藻糖當口服時係可被活體輕易地吸收,代 謝及利用,而作爲能量來源。 實驗4 非經腸投與之體內利用試驗 實驗4 — 1 快速投與 將實驗1 - 2製得之含水晶狀海藻糖溶於精製水中, 以濾膜過濾所得溶液,濃縮並再結晶成無熱原(pyrogen-free) 之含 水晶狀海藻糖 。將 所得晶 體溶於注射用蒸餾水 中配成1Ow/v%溶液,其與兔子血液等張而作爲海藻 糖注射液。使用6隻約2 - 3公斤重的兔子,將注射液以 lg/kg體重的劑量,在1. 5分鐘內迅速地注入其耳 靜脈,然後於預定時間間隔收集血液,測量血液試樣之血 糖濃度(葡萄糖濃度(mg/d ί ))及胰島素濃度( I I I n n J ^ (請先聞讀背面之注意事項再填寫本頁) 本紙張尺度逋用中國國家標準(CNS)A4规格U10X297公釐)-15 - 83.3.10,000 經濟部中央標隼局員工消費合作社印製 422697 A7 _B7_ 五、發明説明(13) 。至於對照組,使用與兔子血液等張之5w /v%葡萄糖溶液,以〇 . 5 g/k g體重的劑量類似地 注入兔子靜脈。各結果爲6隻兔子的平均値,其在時間過 程中之血糖濃度與胰島素澳度各示於圖3與圖4。圖中, 寅線與虛線各代青海藻糖與葡萄糖之結果。 由圖3與圖4之結果可知,無論是血糖濃度或胰島素 濃度的動力情形,投與海藻糖之兔子較投與葡萄糖者有一 時間上的延遲,即在投與後約5 — 3 0分鐘產生極大値。 這些結果透露出當海藻糖係非經腸快速地投與,其可於體 內輕易地水解成葡萄糖,而爲活體代謝,利用,作爲能量 來源。自投與開始至投與6小時後,偵測兔子排出尿液中 _糖類含量,結果顯示兔子尿液中之海藻糖量很低,如同葡 萄糖的例子一樣,亦即其量低於投與海藻糖量之1 0 %, d . s . b . ° 窗驗4 - 2 博涑投與 將實驗4 - 1製得之海藻糖注射液如實驗4 - 1所述 方法般,除了係將注射液於1. 5小時慢慢地注入兔耳靜 脈外,投與6隻兔子(約2 - 3公斤重),於預定時間間 隔收集血液,測量血液試樣之血糖濃度(葡萄糖濃度( rng/dJ?))與胰島素濃度。各結果爲 6隻兔子的平均値,時間過程中之血糖濃度與胰島素浪度 各示於圖5與圖6。 本紙張尺渡適用中國國家揉準(CNS)A4規格(210X297公釐)-_ 83.3.10,000 I 裝 訂 線 (請先聞讀背面之注意事項再填寫本頁) 422697 A7 B7 經濟部中夬標準局貝工消費合作社印裝 五、發明説明(14) 由圖5與圖6的結果得知,雖然投與海藻糖之兔子的 血糖澳度動力情形較投與葡萄糖者有一時間上的延遲,二 者之動力情形實質上相同,又投與海藻糖之兔子的胰島素 澳度動力情形與投與葡萄糖者大致相同。這些結果透露出 當海藻糖係非經腸慢速地投與至活體,其可於體內輕易地 水解成葡萄糖,而爲活體代謝,利用,作爲能量來源。自 投與開始至投與6小時後,偵測兔子排出尿液中之糖類含 量,結果顯示兔子尿液中之海藻糖量很低,如同葡萄糖的 例子一樣,亦即其量低於投與海藻糖量之10%,d. s .b . 0 窗驗5 魚件審伸試驗 使用小白鼠測試海藻糖之急性毒性,即令老與口服寅 驗1 一 2製得之含水晶狀海藻糖。結果顯示海藻糖爲極低 毒性物質,即使投與最高可能劑量時也沒有老鼠死亡。根 據此結果,LD5〇爲5 0 g/k g以上,雖然此値並非很 精確。 下列賁例說明本案含有海藻糖作爲有效成份之補充能 量用組成物。 窗例1 巧克力 將4 0重量份可可糊漿,1 0重量份可可脂,以及 (請先聞讀背面之注意事項再填寫本頁) t •V5 丁 本紙張尺度適用中國國家樣準(CNS ) A4規格(210X297公釐) '17 83. 3.10,000 422697 A7 B7 經濟部中央標準局負工消費合作社印製 五、發明説明(1r) 15 5 0重量份由實驗1 一 2方法製得之含水晶狀海藻糖予以 混合,令所得混合物通過精製機以降低粒子大小,移至精 磨機,於5 0 °C捏和2天。在此捏和步驟中,添加Q. 5 重量份之卵磷脂,並將所得混合物充分捏和。然後藉熱調 節器將混合物保持在3 1°C,在可可脂固化前將之倒入模 子內,以振動器脫氣,通過冷卻隧道,1 〇°C歷2 0分鐘 ,而予以固化。將固化物移出模子,包裝,得到預期產物 〇 此產物大致不具吸濕性,具有令人滿意之顏色,光澤 與組織結構,於口中緩慢地熔化而產生高品質甜味與香味 ,這些性質使其非常適合作爲補充能量用之組成物。 官例2 口香糖 將3重量份之藤基質(gum base)加熱至軟化,與4 重量份蔗糖及3重量份以實驗1 - 3方法製得之晶狀海藻 糖粉末混合,其中並再混有適當香料與色素。以一般方式 用輥子將所得混合物捏和,成形,包裝,得到預期產物。 此產物,即具有令人滿意之組織結構與香味的口香糖 ,可任意地用作爲補充能董用之組成物。 實例3 硬糖果 令1 0 0重置份之5 5%蔗糖溶液在一.面加熱時,一 (請先Μ讀背面之注意事項再填寫本頁) 本紙張尺度逋用中國國家標準(CNS)A4規格(210X297公* > _ lg . 83.3.10,000 422697 A7 _B7 五、發明説明() 16 (請先聞讀背面之注意事項再填寫本頁) 面與3 0重量份高海藻糖含置溶液(由實驗1 一 4之方法 製得)混合,所得混合物於眞空中加熱濃縮,使含水量低 於2 %。此澳縮物與1重量份檸檬酸及適量檸檬香料,色 素混合後,以一般方式將此混合物製成預期產物。 此產物之蔗糖結晶情形充分被抑制了,爲一髙品質硬 糖果’具有令人滿意之味道與口感,適合兩作爲補充能量 用之組成物。 實例4 雞蛋一牛奶—糖軟凍(Custard cream) 經濟部中央標準局員工消费合作社印製 令1 Ο 0重量份玉米澱粉,1 Ο 0重量份含有7 0% 晶狀海藻糖粉末,d. s. b.,之海藻糖糖漿(由實驗 1 一 3之方法製得),8 0重量份麥芽糖,2 0重量份蔗 糖,以及1重量份的鹽予以充分捏和,再令此混合物於攪 拌中與2 8 0重置份新鮮雞蛋混合,然後緩慢地與 1 0 G 0重量份沸騰中的牛奶混合。繼績加熱攪拌所得混 合物,當全部內容成爲半透明時方停止加熱,接著將其冷 卻,並加入適量的香草香料。稱重產物,注入容器中,包 裝得到預期產物。 此產物具有平滑表面及溫和的甜味及昧道,這使其可 任意地用作爲補充能量之組成物。 賨例5 来親粉(米稞之預混物)___ 本紙張尺度適用中國國家標率(CNS)A4规格( 210X297公釐)_ 19 _ 83.3‘10,000 經濟部中央標準局貝工消费合作社印裂 422697 A7 _B7_五、發明説明(17) 將下列成分充分混合物而製得米稞粉:9 0重量份米 之粉末,2 0重量份玉米澱粉,1 2 0重量份晶狀海藻糖 粉末(由實驗1 - 3之方法製得)以及4重量份短根酶多 糖(pullulan)。令此產物與適量抹茶(粉碎之綠茶)以 及水捏和,再將混合物置於容器中蒸煮6 0分鐘以得到米 稞。 此產物具有令人滿意之光澤,口感與香昧。產物中澱 粉之老化作用(retrogradation)充分地被抑制了,此提 供了令人滿意之擱置軎命(she!f-life)。此產物可任意 地用作爲補充能量之組成物。 官例6 到,酸飲料 令1 0重量份脫脂牛奶於8 0°C加熱殺菌2 0分鐘, 冷卻至4 0°C後,與0 . 3重量份菌母(starter)混合 ,於約3 7 °C醱酵1 0小時。然後將此混合物勻化,與4 重量份晶狀海藻糖粉未(由實驗1_ 3的方法製得),1 重量份蔗糖,以及2重量份異構化糖漿混合,所得混合物 再於7 Ot加熱殺菌,接著予以冷卻,與適量香料混合後 裝瓶得到預期產物。 此產物,即高品質乳酸飲料且具有和諧之香味與甜味 ,可任意用作爲補充能量之組成物。 官例7 本紙張尺度逍用中國國家樣準(CNS )八4胁(210X297公釐) 83.3. !0,000 -ZU 一 (請先閲讀背面之注意事項再填寫本x) A7 B7 經濟部中央橾準局員工消費合作,杜印製 五、發明説明(18) 巢汁粉 將下列成份攪拌混勻:3 3重量份喷灑乾燥之橘子果 沬粉末,5 0重量份含水晶狀海藻糖粉末(由實驗1 _ 2 方法製得〉,1 0重量份蔴糖,0. 6 5重量份無水檸檬 酸,0.1重量份蘋果酸鹽,0.1重量份L_抗壞血酸 ,0. 1重量份檸檬酸鈉,0. 5重量份短根酶多糖,以 及適量香料粉末。將此混合物粉碎後餵入流動牀製粒機, 其中之排氣溫度與流速各調整爲4 0°C與1 5 0m3/ m i η,同時並噴灑高海藻糖含量溶液作爲結合劑(其係 由市售海藻糖製得),進行製粒30分鐘。所得粉狀顆粒 稱重後包裝,製得預期產物。 此產物爲30%果汁,d. s. b.,安定期相當長 而不會產生不悅之味道與氣味,也不會因吸收水氣而固化 。所以此產物可任意用作爲補充能量之組成物。 官例8 蛋黃粉 令新鮮雞蛋之蛋黃於6 0 - 6 4 °C以加熱板殺菌,所 得液體以1重量份對4重量份之比例與無水晶狀海藻糖( 由實驗1 一 4的方法製得)混合。所得混合物置於容器中 靜置過夜,其因海藻糖轉變成爲含水晶狀海藻糖而成爲塊 狀。以切割器將該塊狀物粉碎而得到蛋黃粉。 此產物可任意用作爲糖果餅點的材料,例如預混物, 冰淇淋與糖果,亦可用作爲乳化劑,以及口服或插管餵食 本紙張尺度逍用中國國家標準(CMS ) A4規格( 210X297公釐)了 21 - S3 y 10,000 ----------装------IT------d. (請先閲讀背面之注意事項再填寫本頁) 422697 A7 B7 經濟部中央標準局負工消費合作社印裂 五、發明説明(10) iy 之補充能量的組成物。 實例9 插管餵食之固體製物 製備一種由下列成份所組成之組成物:5 0 0重量份 含水晶狀海藻糖(由實驗1 一 2之方法製得),2 7 0重 量份蛋黃粉,2 0 9重量份脫脂牛奶,4 . 4重量份氣化 鈉,1. 8重量份氯化鉀,4重量份硫酸鎂,〇· 〇1重 量份硫胺素,0. 1重量份抗壞血酸鈉,〇. 6重量份維 生素E乙酸酯,以及〇. Q4重量份菸醯胺。將25g此 組成物注入防潮層疊小袋中,熱封而製得預期產物。 將一袋產物溶於約1 5 0 — 3 0 OinL水中成爲流體 食物,口服投與或是非經腸地以插管餵食投與至鼻腔,胃 與腸,而作爲補充能量之組成物。 實例1 0 高營蕃物 將含水晶狀海藻糖粉末(由實驗1 一 2之方法製得) 溶於水中配成約1Ow/v%海藻糖水溶液,以一般方式 用濾膜過濾移除熱原,滅菌地將之注入塑膠瓶中,密封後 便可得到預期產物。 此產物爲令人滿意之安定高營養物,於靜置時大致不 會發生變化,適於靜脈投與以及腹膜內投與。該產物之 1Ow/v%溶液與血液等張,此表示其補充給活體之能 ----------t.— (請先W讀背面之注意事項再填寫本頁) 訂 镍 本紙張尺友適用中囷國家揉準(CNS)A4規格(210X297公釐)· 83.3,10,_ ^2269 / A7 B7 五、發明説明(20) 量以菊萄糖之2倍濃度供給。 窗例1 1 髙營養物 將含水晶狀海藻糖(由寅驗1 — 2之方法製得)與一 由下列成份組成之胺基酸組成物一同搅拌溶於水中,使其 濃度各爲與3 Ow/v%,又如同實例1 〇, 將所得溶液純化成無熱原溶液,然後注入塑膠瓶中,密封 而得到預期產物。 胺基酸組成物之成份 ----------^ — (請先閲讀背面之注意事項再填寫本頁)
成份 mg/100mL 經濟部中央標準局貝工消費合作杜印装 L _異亮胺酸 L 一亮胺酸 L 一賴胺酸單鹽酸鹽 L 一甲硫胺酸 L _苯丙胺酸 L 一蘇胺酸 L —色胺酸 L 一纈胺酸 L -精胺酸鹽酸鹽 L -組胺酸單鹽酸鹽 甘胺酸 1 8 0 4 1 0 6 2 0 2 4 0 2 9 0 18 0 6 0 2 0 0 2 7 0 1 3 0 3 4 0 線 本紙張尺度適用中國國家揉準(CNS)A4規格( 210X297公釐)-23 - 83. 3.10,000 422697 經濟部中央標準局負工消费合作社印«. A7 B7_五、發明説明(21 ) 雖然此產物爲海藻糖與胺基酸之複合營養物,其於靜 置時大致不生變化而具有令人滿意之安定性,適合靜脈投 與或腹膜內投與活體。此產物可用作爲補充能置組成物而 補充能量與胺基酸。 窗例1 2 外傷軟眘 將5 0 0重量份晶狀海藻糖粉末(由實驗1 一 3之方 法製得)與5 0重量份含3 w t %碘之甲醇溶液混合,將 所得溶液再與2 0 0重量份1 Qw/v%短根酶多糖水溶 液混合,製得具有令人滿意之延展性與黏著性的外傷軟育 0 產物中所含的碘具有殺菌活性,且產物中之海藻糖於 活細胞上可作爲補充能量之糖類來源,又因這些產物縮短 治療期,故可適意地治療傷處表面。 苜例1 3 糖衣錠 令作爲核心之1 5 Omg粗製錠片以下述溶液予以包 衣直至其重約爲230mg,d. s. b.,前述溶液係 由下述成份組成:4 0重量份含水晶狀海藻糖(由實驗工 _ 2之方法製得),2重量份具2 0 0 0 0 0平均分子量 之短根酶多糖,3 0重量份水,2 5重量份滑石,以及3 本紙張尺度適用中國國家梯準(CNS)A4规格( 210X297公釐)_ 24 - 83. 3.10,000 ----------^------1T------.^. (請先閲讀背面之注意事項再填寫本頁} 經濟部中央標隼局負工消費合作社印製 422697 A7 _B7_五、發明説明(22) 重量份二氧化鈦。所得錠片再以下述製液予以包衣:6 5 重量份上述相同之含水晶狀海藻糖的新鮮製物,1重量份 短根酶多糖,以及3 4重量份水。如此所得錠片以蠘溶液 施予光澤而製得具有適意外觀之預期產物。 此產物,其可用上述包衣步驟輕易地製得,具有相當 高之耐衝擊性,並可長時期保有其高性質,故適合用作爲 補充能量之組成物。 由上述可看出本案補充能量用之主要由海藻糖組成的 糖類來源具有令人滿意之安定性,大致不具還原力,且具 有易於體內代謝之特性而爲活體用作爲能量來源,前述海 藻糖係由一包括令非還原糖生成酶作用在具還原力之部分 澱粉水解物的步驟之方法製得。另外本案之補充能量用組 成物,其含有海藻糖(由新穎生化技術自還原性部分澱粉 水解物製得)作爲有效成份,擁有可輕易與其他營養素與 藥物混合物而製成更適意之複合營養組成物的特性,以及 可製成療效增强之醫藥組成物的特性。 本文中所述者爲本發明現今認爲的較佳狀況,然應瞭 解到可有各種改良變化,故在本發明精神與範圍內所所有 改良變化均涵括在本案申請專利範圍中。 I 1 n 裝 I II I I I I 線 {請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家揉準(CNS ) A4规格(2丨0X297公釐) -25 - 83. 3.10,000
Claims (1)
- 422697 422β〇 — ·*.一 I . B8六、申請專利範圍 經濟部智慧財產局員工消f合作社印裂 附件A: 第'831 02441號專利申腈案 中文申請専利範圍修正本 民國89年9月修正 1 .—種能量補充劑,包括占總重,基於乾固髖重, 至少1 Ow/w%作爲有效成分之海藻糖|餘者爲用於食 品、化妝品或藥品之物質,其中該海藻糖經由下述之酶作 用而製成: (a )令非還原糖生成酶作用在具還原力且葡萄糖聚 合度爲3以上之部分澱粉水解物之溶液而生成含海藻糖之 糖類溶液; (b) 純化所得糖類溶液以提高海編糖的純度; (c) 回收純化之海藻糖· 2.如申請專利範圔第1項之能量補充劑,包括其他 糖類· 3 ·如申請專利範圍第2項之能置補充劑,包括非糖 類物質· 4. 如申請專利範圔第1項之能置補充劑*其中該步 驟(b )係將步思(a )所得糖類溶液餵入強酸性陽離子 交換樹脂之管柱層析中以提高海藻糖的純度· 5. 如申請專利範團第1項之能纛補充劑,其中,驟 (a )所得糖類溶液包含2 0 — 8 Ow/w%海藻糖,基 於乾固體重· 6. 如申讅專利範園第1項之能置補充劑,其係用於 本紙張尺度通用中國因家標準(CNS>A4规格(210 X 297公* > -------一-----裝i__i —訂! 1_線 (請先閱讀背面之注意事項再填莴本頁) 9 & 2 2 4 A8B8CSS 六、申請專利範圍 口服或非經腸投與· 7 .如申請專'利範圔第1項之能量補充劑,其包含至 少50w/w%海藻糖*基於乾固體重· 8.如申請專利範園第3項之能置補充劑,其係用於 口服或非經腸投與· ^-------------裝--------訂---------線 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印裝 本紙張尺度適用中S困家標準(CNS>A4规格<210 * 297公!8 )
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9351393 | 1993-03-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW422697B true TW422697B (en) | 2001-02-21 |
Family
ID=14084433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW083102441A TW422697B (en) | 1993-03-16 | 1994-03-21 | Energy-supplementing saccharide source and its uses |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0619951B1 (zh) |
KR (1) | KR100306867B1 (zh) |
CN (2) | CN1188133C (zh) |
AT (1) | ATE225131T1 (zh) |
AU (1) | AU681109B2 (zh) |
CA (1) | CA2119070C (zh) |
DE (1) | DE69431455T2 (zh) |
IL (1) | IL108965A (zh) |
TW (1) | TW422697B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5677442A (en) * | 1992-12-28 | 1997-10-14 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Method of crystallizing trehalose without using organic solvent |
ATE182359T1 (de) * | 1992-12-28 | 1999-08-15 | Hayashibara Biochem Lab | Nichtreduzierendes saccharidbildendes enzym, und dessen herstellung und verwendungen |
DE69535865D1 (de) * | 1994-06-15 | 2008-11-27 | Kirin Brewery | Transferase und Amylase, Verfahren zur Herstellung dieser Enzyme, ihre Verwendung und kodierende Gene |
EP0782398A1 (en) | 1994-09-22 | 1997-07-09 | Quadrant Holdings Cambridge Limited | Compositions for use in rehydration and nutrition during athletic exercise and methods of making same |
US5958455A (en) * | 1996-02-09 | 1999-09-28 | Quadrant Holdings Cambridge Ltd | Oral solid dosage forms, methods of making same and compositions thereof |
EP0868916A3 (en) * | 1997-03-04 | 2004-09-15 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Reduction inhibitory agent for active-oxygen eliminating activity |
JP4034862B2 (ja) | 1997-06-02 | 2008-01-16 | 株式会社林原生物化学研究所 | スクロースの後味改善方法とその用途 |
JPH11116588A (ja) | 1997-10-16 | 1999-04-27 | Hayashibara Biochem Lab Inc | トレハロース及び糖アルコールの製造方法 |
GB2356788A (en) * | 1999-12-02 | 2001-06-06 | British Sugar Plc | Trehalose for use in exercise |
US20030003132A1 (en) * | 2000-11-07 | 2003-01-02 | Norie Arai | Mucosal immunomodulator and use thereof |
CN103450288B (zh) * | 2013-08-16 | 2016-05-11 | 齐鲁工业大学 | 一种海藻糖的分离纯化方法 |
CN105996004A (zh) * | 2016-06-08 | 2016-10-12 | 北京蓝丹医药科技有限公司 | 一种能量补充剂 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63216492A (ja) * | 1987-03-05 | 1988-09-08 | Natl Food Res Inst | ネオトレハロ−ス、セント−スの製造法 |
JPS63240757A (ja) * | 1987-03-30 | 1988-10-06 | Natl Food Res Inst | 新規な食品素材 |
JPS63240758A (ja) * | 1987-03-30 | 1988-10-06 | Natl Food Res Inst | 新規食品素材 |
US5035912A (en) * | 1990-06-19 | 1991-07-30 | American Maize-Products Company | Starch jelly candy |
DE4022058C2 (de) * | 1990-07-11 | 1996-05-23 | Oetker Nahrungsmittel | Honigpulver und Verfahren zu seiner Herstellung |
JP3082094B2 (ja) * | 1990-11-15 | 2000-08-28 | 株式会社林原生物化学研究所 | ネオトレハロースの製造方法とその用途 |
CA2055257C (en) * | 1991-09-20 | 2002-07-23 | Takashi Shibuya | Saccharide for supplementing energy to living body, and uses |
JP3172925B2 (ja) * | 1992-02-25 | 2001-06-04 | 株式会社林原生物化学研究所 | ネオトレハロースの製造方法とその用途 |
ATE182359T1 (de) * | 1992-12-28 | 1999-08-15 | Hayashibara Biochem Lab | Nichtreduzierendes saccharidbildendes enzym, und dessen herstellung und verwendungen |
-
1994
- 1994-03-14 IL IL10896594A patent/IL108965A/en active IP Right Grant
- 1994-03-15 CA CA002119070A patent/CA2119070C/en not_active Expired - Lifetime
- 1994-03-16 KR KR1019940005208A patent/KR100306867B1/ko not_active IP Right Cessation
- 1994-03-16 EP EP94301892A patent/EP0619951B1/en not_active Expired - Lifetime
- 1994-03-16 AT AT94301892T patent/ATE225131T1/de not_active IP Right Cessation
- 1994-03-16 CN CNB941029344A patent/CN1188133C/zh not_active Expired - Lifetime
- 1994-03-16 AU AU57823/94A patent/AU681109B2/en not_active Expired
- 1994-03-16 CN CNB2004100384046A patent/CN1279918C/zh not_active Expired - Fee Related
- 1994-03-16 DE DE69431455T patent/DE69431455T2/de not_active Expired - Fee Related
- 1994-03-21 TW TW083102441A patent/TW422697B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1279918C (zh) | 2006-10-18 |
DE69431455T2 (de) | 2003-08-14 |
KR940021067A (ko) | 1994-10-17 |
IL108965A0 (en) | 1994-06-24 |
CA2119070A1 (en) | 1994-09-17 |
ATE225131T1 (de) | 2002-10-15 |
CN1101832A (zh) | 1995-04-26 |
CA2119070C (en) | 2006-11-21 |
AU5782394A (en) | 1994-09-22 |
EP0619951B1 (en) | 2002-10-02 |
AU681109B2 (en) | 1997-08-21 |
IL108965A (en) | 1998-07-15 |
CN1188133C (zh) | 2005-02-09 |
EP0619951A3 (en) | 1995-08-02 |
CN1548049A (zh) | 2004-11-24 |
DE69431455D1 (de) | 2002-11-07 |
EP0619951A2 (en) | 1994-10-19 |
KR100306867B1 (ko) | 2001-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2896598B2 (ja) | ラクトネオトレハロースとその製造方法並びに用途 | |
Martínez-Monteagudo et al. | Lactitol: Production, properties, and applications | |
EP0382355B1 (en) | Growth promoting agent for bacteria containing pullulan with or without dextran | |
JPH03135992A (ja) | 結晶2―O―α―D―グルコピラノシル―L―アスコルビン酸とその製造方法並びに用途 | |
JP3134229B2 (ja) | ラクトスクロース高含有粉末の製造方法とその粉末の用途 | |
Vastenavond et al. | Tagatose (D-tagatose) | |
TW422697B (en) | Energy-supplementing saccharide source and its uses | |
KR0161531B1 (ko) | 락토수크로오스 고함유 분말의 제조방법과 그 분말의 용도 | |
JPH10168093A (ja) | 結晶性粉末糖質とその製造方法並びに用途 | |
JPH0327293A (ja) | α―グリコシル ルチンの製造方法とその用途 | |
JP3381010B2 (ja) | プロポリスエキスを含有する発酵物とその製造方法並びに用途 | |
JPH0413691A (ja) | α―グリコシル ナリンジンとその製造方法並びに用途 | |
JP3072535B2 (ja) | 5−O−α−D−グルコピラノシル−L−アスコルビン酸とその製造方法並びに用途 | |
CA2055257C (en) | Saccharide for supplementing energy to living body, and uses | |
JPH07163386A (ja) | ネオトレハロース構造を有する非還元性オリゴ糖とその製造方法並びに用途 | |
JP2005211078A (ja) | 美容健康食品 | |
JP3125099B2 (ja) | ラクトスクロース含有粉末の製造方法とその粉末の用途 | |
TW449619B (en) | Non-reducing saccharides, their preparations and uses | |
JP2004269488A (ja) | 結晶α−D−グルコシルα−D−ガラクトシドとこれを含有する糖質及びこれらの製造方法並びに用途 | |
JPH06319486A (ja) | エネルギー用糖源とその用途 | |
JP3877589B2 (ja) | エネルギー用糖源とその用途 | |
JP3158217B2 (ja) | エネルギー用糖源とその用途 | |
JPH08217784A (ja) | α−イソマルトシル α−イソマルトシドとその製造方法並びに用途 | |
JPH1057092A (ja) | ラクトスクロース高含有物とその製造方法並びに用途 | |
JP2006342061A (ja) | ミネラル含有水溶液組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent | ||
MM4A | Annulment or lapse of patent due to non-payment of fees |